This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
AAFP, USPSTF Recommend Against Routine Screening for Ovarian Cancer
Literature Shows No Supporting Evidence, Demonstrated Harms
By Matt Brown
"In addition, a high percentage of women who undergo screening will experience a false-positive test and consequently be subjected to unnecessary harms, such as major surgery," LeFevre told AAFP News Now. "Ovarian cancer is … a major cause of cancer death in women, but unfortunately, we don't have an effective way to screen that saves lives, and the methods that we do have available are associated with very high false-positive rates. Therefore, we do a lot of harm without benefit."
- The AAFP, in conjunction with the U.S. Preventive Services Task Force, has reaffirmed its 2004 recommendation against screening for ovarian cancer in asymptomatic women with no known genetic risks for the disease.
- No screening method exists for ovarian cancer that is effective in reducing deaths.
- Not only did a recent literature search find no new evidence to support screening, it also provided new data regarding observable harms.
"It's clearly something that physicians should not do," Campos-Outcalt said. "They should not be screening for ovarian cancer because it simply does not work, and it will lead to a bunch of unnecessary follow-up testing and interventions that aren't going to make any difference in the outcome."
LeFevre said it is important to point out that the recommendation applies to asymptomatic women without a known genetic mutation, such as in the BRCA1 or BRCA2 gene, that increases the risk for ovarian cancer.
"I don't think we have good information about what to do with those patients," he said, "but this recommendation doesn't apply to them."
The Academy and the task force are in good company with regard to their position on screening for this disease, according to LeFevre. Many other major health and medical associations, including the American Cancer Society and the American College of Obstetricians and Gynecologists also recommend against screening asymptomatic women with no known risk factors for ovarian cancer.